Vaxcyte, Inc. PCVX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Roger Song | Jefferies | 106.735 $ | 146 $ | 39.27 % | 06/11/2024 |
| David Risinger | Leerink Partners | 106.735 $ | 135 $ | 28.27 % | 06/11/2024 |
| Salim Syed | Mizuho Securities | 115.28 $ | 163 $ | 47.72 % | 10/09/2024 |
| Jason Gerberry | Bank of America Securities | 110.15 $ | 140 $ | 29.85 % | 04/09/2024 |
| David Risinger | Leerink Partners | 112.04 $ | 153 $ | 40.96 % | 03/09/2024 |
| Tom Shrader | BTIG | 110.15 $ | 160 $ | 49.85 % | 03/09/2024 |
| Roger Song | Jefferies | 111.125 $ | 129 $ | 17.88 % | 03/09/2024 |
| Salim Syed | Mizuho Securities | 111.085 $ | 113 $ | 1.92 % | 03/09/2024 |
| Tom Shrader | BTIG | 70.52 $ | 98 $ | 27.48 % | 07/08/2024 |